Literature DB >> 13620781

Hyperlipemia in early stages of acute glomerular nephritis.

W HEYMANN, S G WILSON.   

Abstract

Entities:  

Keywords:  GLOMERULONEPHRITIS/blood in; LIPIDS/in blood

Mesh：

Substances：

Year:  1959        PMID： 13620781      PMCID： PMC444124          DOI： 10.1172/JCI103787

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  The causal role of plasma albumin deficiency in experimental nephrotic hyperlipemia and hypercholesteremia.

Authors:  R H ROSENMAN; M FRIEDMAN; S O BYERS
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

2.  Studies on the causal role of hypoalbuminemia in experimental nephrotic hyperlipemia.

Authors:  W HEYMANN; G NASH; C GILKEY; M LEWIS
Journal:  J Clin Invest       Date:  1958-06       Impact factor: 14.808

3.  Difference in color of hematuria in the nephrotic syndrome and glomerulonephritis.

Authors:  W HEYMANN; M B ROTHENBERG; C GILKEY; M LEWIS
Journal:  Pediatrics       Date:  1958-03       Impact factor: 7.124

4.  Natural history of glomerulonephritis.

Authors:  D P EARLE; D SEEGAL
Journal:  J Chronic Dis       Date:  1957-01

5.  Microbiologic aspects of glomerulonephritis.

Authors:  C H RAMMELKAMP
Journal:  J Chronic Dis       Date:  1957-01

6.  THE INTERRELATIONS OF SERUM LIPIDS IN PATIENTS WITH DISEASES OF THE KIDNEYS.

Authors:  J P Peters; E B Man
Journal:  J Clin Invest       Date:  1943-09       Impact factor: 14.808
  6 in total
  3 in total

1.  Nephrotic syndrome. Clinical, biochemical and histological correlation.

Authors:  M L Magotra; G P Andurkar
Journal:  Indian J Pediatr       Date:  1976-06       Impact factor: 1.967

2.  Nephrotic syndrome.

Authors:  L E Earley; R J Havel; J Hopper; H Grausz
Journal:  Calif Med       Date:  1971-11

3.  Expression of THSD7A in neoplasm tissues and its relationship with proteinuria.

Authors:  Li Xian; Dandan Dong; Jiamei Luo; Ling Zhuo; Ke Li; Ping Zhang; Wei Wang; Ying Xu; Gang Xu; Li Wang; Guisen Li
Journal:  BMC Nephrol       Date:  2019-08-23       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.